153Sm-EDTMP With or Without a PSA/TRICOM Vaccine To Treat Men With Androgen-Insensitive Prostate Cancer
Condition(s):Prostate CancerLast Updated:January 4, 2017Completed
Hide Studies Not Open or Pending
Condition(s):Prostate CancerLast Updated:January 4, 2017Completed
Condition(s):Prolactinoma; Prolactin-Producing Pituitary Tumor; Pituitary Tumor; Prolactinoma Macroadenoma; Prolactinoma MicroadenomaLast Updated:July 5, 2023Terminated
Condition(s):Prostate CancerLast Updated:September 11, 2017Completed
Condition(s):Prostate CancerLast Updated:November 29, 2018Completed
Condition(s):Skin ManifestationsLast Updated:August 1, 2022Completed
Condition(s):Dysphagia; Swallowing DisordersLast Updated:August 23, 2023Recruiting
Condition(s):Skin ManifestationsLast Updated:August 1, 2022Completed
Condition(s):HealthyLast Updated:August 31, 2023Enrolling by invitation
Condition(s):Fear PainLast Updated:May 16, 2023Recruiting
Condition(s):StrokeLast Updated:November 16, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.